ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Obstetric and Pediatric Pharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1612169

Insights on pediatric medication initiation: Perceptions of caregivers and children

Provisionally accepted
Maria  Rubio-valeraMaria Rubio-valera1,2,3,4*Cristina  Carbonell-DuacastellaCristina Carbonell-Duacastella3,4Maria  Teresa Peñarrubia-MariaMaria Teresa Peñarrubia-Maria3,5,6Eva  PachecoEva Pacheco5,6Patricia  Gabriela-RicciardeliPatricia Gabriela-Ricciardeli1Ignacio  Aznar-LouIgnacio Aznar-Lou1,3Montserrat  Gil-GirbauMontserrat Gil-Girbau1,4,7
  • 1Parc Sanitari Sant Joan de Déu, España, Spain
  • 2University of Barcelona, Barcelona, Catalonia, Spain
  • 3Center for Biomedical Research in Epidemiology and Public Health Network, Carlos III Health Institute (ISCIII), Madrid, Madrid, Spain
  • 4Sant Joan de Déu Research Institute (IRSJD), Esplugues de Llobregat, Spain
  • 5Catalan Health Institute (ICS), Barcelona, Catalonia, Spain
  • 6Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Cornellà de Llobregat, Spain
  • 7Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Barcelona, Balearic Islands, Spain

The final, formatted version of the article will be published soon.

Children fail to initiate a high proportion of medications but little is known about motivations for non-initiation.To explore the factors affecting the decision to initiate a medication prescribed to children from caregivers' and children's perspectives.Qualitative study based on Grounded theory using a constructivist approach. Twenty-one caregivers and six children (<18 years old) were individually interviewed between 2021-2022 in Spain using a semi-structured thematic guide. Interviews were transcribed and analyzed by pharmacists, pediatricians and family physicians through a constant comparative analysis and results were internally audited.Caregivers and healthcare professionals are the central figures involved in the decision-making process regarding treatment initiation; children were rarely involved. Caregivers, usually mothers, made a risk-benefit evaluation based on the perception of the disease and the medication, which was influenced by intrapersonal factors (emotional burden, health literacy and stigma); childrenrelated factors (age, treatment and emotional burden); and factors related to the professionals (accessibility, discourse alignment, information, respect and emotional support, trust and specialty); healthcare system (trust and use of e-consultations) and context (media, peer pressure and social stigma).The decision to initiate medication in the pediatric population is multifactorial and influenced by perceptions on the disease and treatment, intrapersonal factors related to the caregivers and children, and interpersonal factors and factors related to the healthcare system and contexts. An informed, shared decision-making process that considers both the participation of children and the needs for support from caregivers when prescribing a treatment could promote initiation in the pediatric population.

Keywords: Pediatrics, Medication Adherence, qualitative research, medication, Patient Participation

Received: 16 Apr 2025; Accepted: 23 May 2025.

Copyright: © 2025 Rubio-valera, Carbonell-Duacastella, Peñarrubia-Maria, Pacheco, Gabriela-Ricciardeli, Aznar-Lou and Gil-Girbau. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Maria Rubio-valera, Parc Sanitari Sant Joan de Déu, España, Spain

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.